Skip to main content
TipRanks
Go Ultimate75% OFF

Compagnie de Saint-Gobain SA (GOBU) Q2 2026 Earnings Report

2 Followers

DE:GOBU Q2 2026 EPS Results

Actual EPS
EUR 0.36
Consensus EPS
EUR 0.32
Beat/Miss
Beat by +EUR 0.03
One Year Ago EPS
EUR 0.38

DE:GOBU Q2 2026 Revenue Results

Actual Revenue
EUR 24.88B
Expected Revenue
EUR 12.63B
Beat/Miss
Beat by +EUR 12.25B
YoY Revenue Growth
+5.65%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
After Close
Conference Call
Thursday, July 30, 2026
DE:GOBU Upcoming Earnings

Compagnie de Saint-Gobain SA's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:GOBU Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 30, 2026|% Change Since:0.00%|
Earnings Call Sentiment|Positive

The call presents a predominantly positive operational and strategic picture: solid Q2 acceleration, strong EBITDA margin (15.4%), robust free cash flow (EUR 2.1bn) and active, accretive portfolio rotation (~EUR 3bn YTD). Key growth engines—construction chemicals and Asia Pacific—delivered strong outperformance and management reiterated >15% EBITDA target for 2026. Headwinds include H1 negative price-cost spread, FX dilution (-1.3%), a modest EPS decline (-2.6%), and ongoing inflation/geo‑political uncertainty. On balance the positive financial performance, cash generation, strategic M&A and execution of the Lead & Grow plan outweigh the challenges.

Company Guidance

Management reiterated a 2026 outlook combining continued like‑for‑like growth across regions with disciplined margin and cash targets: they expect a slight positive price‑cost spread for the year, an EBITDA margin above 15% (H1 15.4%), and H2 like‑for‑like sales growth after H1 +0.7% (Q2 +3.5%; Asia‑Pacific H1 +7.0% like‑for‑like, Europe H1 +1.7%, North America Q2 +1.2%); construction chemicals remain a key growth engine (Q2 organic +8.5%, target ~€9bn sales by 2030). Key financial metrics: recurring net income €1.7bn (H1), free cash flow €2.1bn (H1) with 65% cash conversion on EBITDA (125% on recurring NI), operating working capital 24 days, CapEx ~€2bn FY, net debt ratio 1.6x, H1 ROCE 13.5% (target >13% over the plan), EPS down 2.6% in local currencies, tax rate ~25%, depreciation +3%, and non‑operating costs expected slightly below €250m p.a. Operational and portfolio actions: prices +0.8% H1 (up 1.6% in Q2; realized pricing noted ≈1.8%), FX headwind −1.3% H1, structure −0.5% H1, energy <4% of sales and ~75% hedged for 2026, ~90% of CapEx/M&A deployed in high‑growth markets, and 23 transactions YTD rotating ~€3bn of sales (≈40–50bp margin accretion on a full‑year basis and roughly one‑third of the >20% sales‑rotation target to 2030); overall guidance emphasizes outperformance, margin, cash and disciplined capital allocation.

  • Organic Sales Growth (H1 and Q2)Like-for-like sales growth +0.7% in H1 2026 and +3.5% in Q2 2026, with all regions growing in Q2 (Asia Pacific +7% LFL in H1, Europe Q2 +4%, North America Q2 +1.2%).
  • Strong Profitability MetricsEBITDA margin of 15.4% in H1 2026 and management guidance of >15% for 2026 full year; regional EBITDA margins include Americas 19.5% and Asia Pacific record 18.5%.
  • Robust Recurring Profit and Cash GenerationRecurring net income ~EUR 1.7 billion in H1; free cash flow EUR 2.1 billion with cash conversion of 65% on EBITDA and 125% on recurring net income; operating working capital stable at 24 days.
  • Active Portfolio Rotation and M&A Execution23 acquisitions/divestments signed or closed in H1; ~EUR 3 billion of sales rotated year-to-date (≈1/3 of the >20% sales rotation target by 2030).
  • Construction Chemicals OutperformanceConstruction chemicals strongly outperformed with +8.5% organic sales growth in Q2 and continued double-digit growth in key markets (India, North America construction chemicals momentum).
  • Investment in Growth Capabilities and Footprint13 of 14 new lines/plants opened in H1 across North America, Asia and emerging markets; ~90% of gross CapEx and M&A invested in high-growth regions; CapEx expected ~EUR 2 billion for 2026.
  • Balance Sheet Strength and Shareholder ReturnsNet debt ratio 1.6x; EUR 1.4 billion returned to shareholders in H1 including EUR 292 million share buybacks, reflecting disciplined capital allocation.
  • Regional Outperformance — Asia PacificAsia Pacific growth 8.4% in local currencies and 7% LFL in H1, broad-based across India, Southeast Asia, China and Australia; region delivered a record EBITDA margin of 18.5%.
  • Pricing Realization and Energy HedgingPrices up 0.8% in H1 and up 1.6% in Q2 (management later cites ~1.8% in Q2 pricing momentum); energy bill <4% of group sales with ~75% of 2026 energy exposure hedged.
  • Operational & Strategic Execution — Lead & GrowManagement highlights strong execution of the Lead & Grow plan: solution rollouts, cross-selling (example: Eastern Europe cross-selling ≈+1% growth contribution), AI deployment, and targeted acquisitions (Xypex, AGC Polymer Materials).

DE:GOBU Earnings History

DE:GOBU earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)0.29-0.33――
Jul 30, 20262026 (Q2)0.320.360.38-5.49% (-0.02)
Feb 26, 20262025 (Q4)0.310.330.47-29.84% (-0.14)
Jul 31, 20252025 (Q2)0.380.380.3313.55% (+0.05)
Feb 27, 20252024 (Q4)―0.230.28-18.10% (-0.05)
Jul 26, 20242024 (Q2)―0.330.35-5.87% (-0.02)
Feb 29, 20242023 (Q4)0.290.280.280.64% (+0.00)
Jul 26, 20232023 (Q2)―0.350.3210.11% (+0.03)
Feb 23, 20232022 (Q4)0.290.280.2512.19% (+0.03)
Jul 27, 20222022 (Q2)0.620.320.315.33% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed